gamma-secretase modulator 1
CAS No. 1172637-87-4
gamma-secretase modulator 1( N-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine )
Catalog No. M26225 CAS No. 1172637-87-4
gamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 29 | In Stock |
|
| 5MG | 43 | In Stock |
|
| 10MG | 77 | In Stock |
|
| 25MG | 151 | In Stock |
|
| 50MG | 237 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namegamma-secretase modulator 1
-
NoteResearch use only, not for human use.
-
Brief Descriptiongamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
-
Descriptiongamma-secretase modulator 1 is a modulator of γ secretase and can be used in studies about the treatment of Alzheimer's disease.
-
In Vitro——
-
In Vivo——
-
SynonymsN-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4-phenyl-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine
-
PathwayNeuroscience
-
TargetGamma-secretase
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1172637-87-4
-
Formula Weight416.54
-
Molecular FormulaC24H24N4OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(Nc2nc3C(CCCc3s2)c2ccccc2)ccc1-n1cnc(C)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Huang J, Zhou Z, Zhou M, Miao M, Li H, Hu Q. Development of benzoxazole deoxybenzoin oxime and acyloxylamine derivatives targeting innate immune sensors and xanthine oxidase for treatment of gout. Bioorg Med Chem. 2018 May 1;26(8):1653-1664.
molnova catalog
related products
-
Genz-123346 free bas...
Genz 123346 is an inhibitor of GL1 synthase that blocks the conversion of ceramide to GL1.
-
Brontictuzumab
Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway.
-
YO-01027
YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
Cart
sales@molnova.com